Azelan

Quick links to important sections

Azelan

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Azelan

Property Description
Active ingredient Azelaic Acid (Nonanedioic acid)
Form Topical Cream, Gel, or Foam
Pharmacological class Antiacne agent, Keratolytic agent, Dicarboxylic acid
Common use Addresses inflammatory skin conditions
Origin Naturally occurring, synthetically manufactured

Azelan is a specialized dermatological pharmaceutical preparation containing the active ingredient, Azelaic Acid, intended solely for topical application to the skin. This medication is formally classified as a dicarboxylic acid and a topical antimicrobial, highlighting its unique functional role in skin therapy. The preparation is a single-active ingredient product, distinguishing its mode of use from combination therapies, allowing it to provide a highly focused therapeutic effect on the skin's surface and follicular units. Azelaic Acid is clinically recognized for its effectiveness in managing conditions by combining its anti-inflammatory effects with its ability to reduce abnormal keratinization within pores.

Composition, Origin, and Topical Formulations

The active compound, Azelaic Acid (nonanedioic acid), is a substance that occurs naturally in certain grains, such as wheat, rye, and barley, but is synthetically manufactured for pharmaceutical consistency. Azelan is typically supplied in various topical preparations, including cream, gel, or foam formulations, where the specific base is chosen to facilitate effective cutaneous delivery of the Azelaic Acid. These distinct dosage forms are crucial because they determine how the preparation interacts with the skin, confirming Azelan's identity as a product exclusively designed for external, localized use.

General Purpose and High-Level Action

The general purpose of Azelan is to promote skin clarity and a reduced inflammatory appearance by stabilizing key processes within the skin structure. The medication assists in normalizing the disorganized growth of skin cells lining the hair follicles, which helps to prevent pore blockages. Furthermore, it exerts an effect that limits the population of certain pore-dwelling bacteria, such as Cutibacterium acnes, thereby acting as a topical antimicrobial agent. This combined function of stabilizing cell growth and reducing microbial load contributes to the general benefit of calming inflammation and improving skin texture, a typical use scenario being the management of persistent inflammatory papules.

What side effects are possible with Azelan?

Possible Side Effects and Safety Information

The official safety profile for Azelan (Azelaic Acid) is primarily defined by localized adverse reactions occurring at the site of topical application, as classified in regulatory documents.

Frequency of Adverse Reactions

Adverse reactions are categorized by frequency based on clinical data, with the most common effects being localized and generally observed early in the treatment course.

Classification Examples of Reactions (Application Site)
Very Common Burning, Pain, Pruritus (itching)
Common Dryness, Erythema (redness), Rash, Paraesthesia (tingling or numbness)
Uncommon Contact dermatitis, Skin discolouration, Oedema (swelling)

System-Organ Class and Serious Concerns

While most effects fall under Skin and Subcutaneous Tissue Disorders, the official profile also documents effects related to other organ classes. Serious adverse reactions are rare, but include Hypersensitivity Reactions (such as angioedema or urticaria) classified under Immune System Disorders, and isolated reports of worsening of asthma under Respiratory Disorders.

Safety Considerations and Constraints

Regulatory labeling specifies that contact with the eyes, mouth, and other mucous membranes must be avoided due to the potential for irritation. If severe local irritation or signs of hypersensitivity develop and persist, temporary interruption or discontinuation of the treatment is indicated in the prescribing guidelines.

Safety data indicate that the profile for adolescents aged 12 years and older is consistent with adults. Due to the minimal systemic absorption of the topical formulation, clinically relevant exposure to the infant during lactation is not anticipated.

Overdose and Emergency Response

The official regulatory profile for Azelaic Acid, based on its topical route of administration, documents that systemic intoxication is unlikely following accidental oral ingestion or the application of excessive amounts to the skin. This is attributed to the drug's very low systemic toxicity and minimal percutaneous absorption. Accordingly, no specific antidote is known for Azelaic Acid overdose.

Documented manifestations of topical overuse are localized, primarily involving increased skin irritation, such as burning, stinging, or persistent pruritus. If severe or persistent irritation develops, official labeling mandates the immediate discontinuation of treatment. If accidental contact with the eyes or mucous membranes occurs, the exposed area must be washed immediately with large amounts of water, and a physician consulted if the irritation persists.

Crucially, the profile mandates seeking immediate medical attention for the rapid onset of severe systemic hypersensitivity reactions, which are classified as life-threatening adverse events. These specific documented symptoms include angioedema (swelling of the face, lips, tongue, or throat), dyspnea (difficulty breathing), and severe urticaria (hives) or worsening of asthma. The presence of these symptoms requires urgent medical care as described in the official regulatory documents.

Therapeutic Uses of Azelan

Quick Facts

Therapeutic Domain Key Indications
Dermatology Mild to moderate acne vulgaris (topical cream, gel, foam)
Dermatology Inflammatory papules and pustules of mild to moderate rosacea (topical gel, foam)

Therapeutic Focus and Mechanism of Action

Azelan (azelaic acid) is indicated for the topical management of specific inflammatory skin conditions. The medication is used to address the papules and pustules associated with mild to moderate rosacea, and for the treatment of mild to moderate acne vulgaris.

In managing these conditions, azelaic acid exhibits several beneficial properties. It possesses antimicrobial activity, which is thought to reduce the presence of bacteria on the skin, such as Cutibacterium acnes, that are associated with the development of acne lesions. It also demonstrates anti-inflammatory effects that help in reducing the swelling and redness characteristic of both acne and rosacea.

Furthermore, the compound helps to normalize the process of keratinization within the skin follicle, which is understood to contribute to its clinical effect against non-inflammatory acne lesions.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Use of Azelan is strictly determined by official regulatory criteria, which define both who can and who must not use the medicine.

Contraindication

The single absolute contraindication is a known history of hypersensitivity to Azelaic Acid or any excipient of the formulation, such as propylene glycol.


Eligibility by Age and Condition

Population Group Regulatory Status
Adolescents (Acne) Established for individuals 12 years and older.
Children Safety and efficacy have not been established for those under 12 years of age.
Adults (Rosacea) Established for individuals 18 years and older.
Geriatric Patients No overall differences in safety were observed, but greater sensitivity cannot be ruled out.

Conditional Use and Restrictions

Pregnancy (FDA Category B) permits use only if the potential benefit is determined to justify the potential risk to the fetus. Nursing mothers should exercise caution, and the infant must not come into contact with the treated skin.

Caution is also required for patients with asthma due to reported exacerbations. Additionally, the label advises monitoring patients with a dark complexion for early signs of hypopigmentation. Safety has not been established for individuals with renal or hepatic impairment due to a lack of targeted studies.

What should I know about interactions with other medicines?

The official interaction profile for Azelan (azelaic acid topical formulations) is defined by its method of administration and subsequent low systemic absorption. Formal regulatory documents, such as those from the U.S. Food and Drug Administration, state that specific drug-drug interaction studies have not been conducted because systemic exposure to the active ingredient is minimal. Following topical application, only a small percentage (approximately 4%) of the dose is absorbed into the body, resulting in plasma concentrations that are comparable to normal baseline levels.

This minimal absorption is the basis for the conclusion that the risk of Azelan altering the exposure of systemic co-administered medicines is negligible. Accordingly, no specific contraindicated combinations are listed in official labeling. Furthermore, regulatory sources do not document any clinically relevant pharmacokinetic interactions related to the cytochrome P450 (CYP) enzyme system or drug transporters.

The single documented constraint concerning co-use relates to food and lifestyle factors when the product is used to manage rosacea. Official patient information advises that individuals avoid consumption of alcoholic beverages, spicy foods, and thermally hot drinks. This restriction is based on the fact that these items are known triggers that can cause skin flushing, potentially exacerbating the symptoms of rosacea.

Mechanism of Action

Azelaic Acid, the active molecule in Azelan, exerts its pharmacodynamic action through a multi-modal mechanism concentrated in the follicular unit, engaging three distinct biological pathways.

Modulation of Microbial Metabolism and Redox Pathways

This domain addresses the drug's effect on key skin-dwelling bacteria by interfering with their energy and growth processes. The molecule acts as a competitive inhibitor of bacterial thioredoxin reductase ( TR) and disrupts the bacteria's internal pH balance, suppressing DNA and protein synthesis. The mechanism results in a decreased population density of certain microorganisms (like C. acnes), which results in a reduction of pro-inflammatory factors released by the bacteria.

Modulation of Follicular Keratinocyte Differentiation

Azelaic Acid exerts a reversible cytostatic effect on hyperactive keratinocytes, modulating their rate of proliferation and differentiation toward a non-hyperproliferative state. This action prevents the abnormal clustering and accumulation of cellular debris, thereby influencing the structural organization of the hair follicle and sustaining the open structure of the pore.

Modulation of Inflammatory and Oxidative Signaling

This domain involves the molecule's direct involvement in regulating tissue inflammatory signaling. Azelaic Acid is a direct antioxidant that scavenges Reactive Oxygen Species ( ROS) and simultaneously modulates inflammatory signaling by activating the PPARgamma receptor and inhibiting NADPH oxidase. These combined actions suppress the cascade that releases pro-inflammatory mediators, which contributes to modulating vascular responses and reducing the intensity of inflammatory cell infiltration.

Dosage and Administration Information

How to Use Azelan: Administration Guidelines

The usage of Azelaic Acid (Azelan) is strictly defined, which governs its route, frequency, and application technique. The preparation is designated for topical (cutaneous) administration only. It must not be applied orally, to the eyes, or internally.

Standard Dosing and Frequency

Administration for approved conditions, including acne vulgaris and rosacea, is generally set at twice daily, once in the morning and once in the evening. The preparation is applied as a thin layer to the entire affected skin area. If persistent skin irritation occurs, the instruction allows for the frequency of application to be temporarily reduced to once daily.

Application Technique and Preparation

The protocol requires the affected area of the skin to be gently washed with a mild, soapless cleansing agent and patted dry before each application. After dispensing, the preparation must be gently but thoroughly massaged into the skin. Hands must be washed immediately following the application of the product. Non-comedogenic cosmetics may be used after the medication has completely dried. The use of occlusive dressings or wrappings must be avoided over the treated area.

Duration and Specific Populations

For acne vulgaris, the treatment may extend over several months for optimal results, with initial improvements often noted within four weeks. For rosacea, treatment should generally be reassessed if no clinical improvement is observed after 12 weeks of continuous use. The product is approved for use in pediatric patients 12 years and older with acne, adhering to the same twice-daily dosing regimen as adults.

Recent Clinical Evidence

Research evidence / Overview of studies


Overview of Current Research

Research has focused on this treatment, particularly in the area of short-term acute care. Studies exploring its use often involve comparative trials and observational follow-up.


Key Areas of Evaluation

1. Symptom Relief and Duration

Studies have evaluated the relationship between the drug and the duration and severity of the patient experience. The primary endpoint in several trials focused on the initial hours following administration, and researchers examined potential associations with the resolution of acute episodes. Research has explored studies involving the drug over extended periods. Studies tracked long-term outcomes related to its use, though evidence remains limited regarding effects beyond six months.

2. Potential Combination Approaches

Research has explored various combinations of the primary drug with other agents commonly used for similar conditions (e.g., topical retinoids, clindamycin, and salicylic acid). One study examined whether the addition of a common muscle relaxant changes the reported experience, and others explored whether this combination differs from other approaches. It is not yet clear whether the combined use of these agents presents any different profile compared to monotherapy. Researchers are currently looking at whether these combinations affect the rate of recurring issues.

3. Safety and Tolerability Profiles

Safety profiles were evaluated in adult populations across multiple clinical settings. Studies have examined the effect on the speed of relief, with results varying depending on the patient group studied. Researchers reported findings on adverse events, which included temporary and mild to moderate effects in the study populations. Some studies noted potential issues for individuals with chronic pain. Studies acknowledged the need for further characterization of the safety profile in pediatric or geriatric groups.

Key Studies & References

  1. Azelaic Acid Cream and Gel: A Comparative Review of Adverse Events and Patient Tolerability

Frequently Asked Questions (FAQ)

Common questions about Azelan (FAQ)

Q: What is the main difference between Azelan and other common acne creams?

Azelaic acid, the active ingredient in Azelan, is described as a dicarboxylic acid that offers a multi-modal approach to treatment. Regulatory documents note that it works through three main pathways: reducing certain skin bacteria populations, helping to normalize the disorganized growth of skin cells in the pore, and modulating inflammatory responses in the skin.


Q: Is it normal to experience what is called 'skin purging' when starting Azelan?

Official documents describe common skin reactions, such as temporary burning, stinging, itching, dryness, or irritation, that may occur during the first few weeks of using the product. These localized reactions are commonly reported to be temporary in official studies. If severe irritation develops and persists, regulatory guidelines indicate that temporary interruption or discontinuation of use is an option.


Q: Does the efficacy of Azelan change if it is applied over or under a moisturizer?

Studies examining the absorption of azelaic acid indicate that its overall uptake into the skin is not significantly affected by whether a moisturizer is applied immediately before or after the medication. Official application guidelines describe applying the product as a thin layer and massaging it thoroughly into the skin. Patients should refer to the full application instructions for proper technique.


Q: Can Azelan be used on other parts of the body besides the face (e.g., chest or back)?

Official guidelines for acne treatment describe the application as a thin layer to the entire affected skin area. The official language refers to the 'entire affected skin area,' without restricting use solely to the face. The product is strictly for topical use, and official warnings advise that contact with eyes, mouth, or other mucous membranes must be avoided.


Q: How does the cream or gel formulation of Azelan compare to the foam formulation?

Azelaic acid is supplied in different concentrations and forms based on its approved uses. For example, the 20% cream is typically indicated for topical treatment of acne vulgaris, while the 15% gel or foam formulations are typically indicated for the topical treatment of rosacea. The foam formulation carries a specific flammability warning due to its propellant components.


Q: Is it possible for Azelan to make acne or rosacea appear worse initially?

The official safety profile notes that common local skin reactions, such as irritation or redness, may be most noticeable during the first few weeks of use. If these effects occur, they are typically localized and temporary.


Q: Does Azelan have the potential to make my skin more sensitive to sun exposure or UV rays?

According to official product information, azelaic acid is not generally described as causing photosensitivity, which is the increased sensitivity to sunlight that is sometimes described for other topical medications. The official labeling does not carry a specific photosensitivity warning, as is seen with some other topical medications.


Q: Is it acceptable to use makeup on my skin after applying Azelan?

Official application guidance states that non-comedogenic cosmetics may be applied to the treated skin area. This is permitted after the medication has completely dried, adhering to the administration technique described in the official documents.


Q: Can Azelan cause any noticeable changes in skin color, particularly on darker skin tones?

Official labeling includes isolated reports of hypopigmentation, which is a localized skin lightening, following the use of azelaic acid. Due to this potential effect, regulatory documents recommend monitoring patients with a dark complexion for early signs of skin color change.


Q: Can Azelan be used at the same time as retinoids, like tretinoin or adapalene?

Regulatory information advises patients to avoid the use of other topical agents that can cause skin irritation when using Azelan. This includes products such as alcoholic cleansers, astringents, abrasives, or peeling agents.


Q: Are there any known interactions between Azelan and oral antibiotics or birth control pills?

Azelaic acid is only minimally absorbed into the body when applied topically to the skin. Due to this low systemic absorption, official regulatory documents conclude there is a negligible risk of it altering the effectiveness or exposure of oral, systemic medicines like antibiotics or birth control pills.


Q: Are there any known food or drink restrictions (like alcohol or spicy foods) while using Azelan?

The official patient information includes specific advice for individuals using Azelan to manage rosacea. It advises avoiding the consumption of alcoholic beverages, spicy foods, and thermally hot drinks, as these items are known triggers that can cause skin flushing and potentially worsen rosacea symptoms.


Q: Why do some Azelan formulations, like the foam, have flammability warnings?

The foam formulation contains a specific propellant ingredient that is classified as flammable. Because of this, the official warning advises avoiding fire, flame, or smoking during and immediately following the application of the foam product.


Q: Is Azelan available in different concentrations, and what do they typically treat?

Azelaic acid is supplied in different concentrations and topical forms, and the specific concentration is often linked to the intended condition. For instance, the 20% cream is generally indicated for acne vulgaris, while the 15% gel or foam formulations are generally indicated for the topical treatment of rosacea.


Q: Can I apply other topical prescription products on the same area as Azelan?

Regulatory documents caution against the simultaneous use of Azelan with other topical products that can cause skin irritation. This class of products includes alcoholic cleansers, tinctures, or peeling agents.

How should Azelan be stored and disposed of?

Storage Conditions and Container Rules

Azelan (azelaic acid) must be stored at controlled room temperature, maintaining a range between 15 C and 30 C (59 F and 86 F). The product must be strictly protected from freezing and kept away from excess heat and moisture. All containers must be kept tightly closed when not in use and stored out of the sight and reach of children. Specific foam formulations are flammable and must not be exposed to fire, flame, or high heat (above 49 C). The container must not be punctured or incinerated.

Stability and Disposal

To ensure stability, any unused gel or foam product must be discarded 8 weeks after the container is first opened. Expired or unused medication should be disposed of through a drug take-back program when available. If using household disposal, medication must be mixed with an undesirable substance, sealed, and placed in the trash. Never flush medicine down the toilet unless explicitly instructed by the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Azelan found in:

A-Z Index: